EudraCT Number: 2021-005504-36 Sponsor Protocol Number: ABNCoV2-03 Start Date: 2022-09-19
Sponsor Name: Bavarian Nordic A/S
Full Title: Evaluation of the Immunogenicity, Safety, and Tolerability of a Single Dose of ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2: a Phase 3 Trial in Two Parts—Randomized, Doubl...
Medical condition: COVID-19 disease
Disease: Version SOC Term Classification Code Term Level
23.1 10042613 - Surgical and medical procedures 10084457 COVID-19 immunisation PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-005573-12 Sponsor Protocol Number: LP0162-1335 Start Date: 2022-09-02
Sponsor Name: LEO Pharma A/S
Full Title: A single (assessor) blinded, randomised, parallel-group, monotherapy trial to evaluate the pharmacokinetic and safety of tralokinumab in children (age 2 to
Medical condition: Atopic dermatitis
Disease: Version SOC Term Classification Code Term Level
21.1 100000004858 10003639 Atopic dermatitis LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: CZ (Ongoing) NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-005178-25 Sponsor Protocol Number: 216152 Start Date: 2022-08-22
Sponsor Name: GlaxoSmithKline Biologicals SA
Full Title: A Phase 1/2a, observer-blind, randomized, controlled, two-stage, multi-country study to evaluate the safety, reactogenicity, and immune response of the trivalent vaccine against invasive nontyphoid...
Medical condition: Healthy volunteers (prevention of invasive nontyphoidal Salmonella disease and typhoid fever)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: BE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2019-004183-21 Sponsor Protocol Number: IP-001-18 Start Date: 2022-08-19
Sponsor Name: Iperboreal Pharma Srl
Full Title: A Study to Evaluate the EffIcacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis
Medical condition: End-Stage Renal Disease (ESRD)
Disease: Version SOC Term Classification Code Term Level
21.0 10038359 - Renal and urinary disorders 10077512 End stage renal disease PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) DK (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-004979-14 Sponsor Protocol Number: AR-320-003 Start Date: 2022-08-18
Sponsor Name: Aridis Pharmaceuticals, Inc.
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Efficacy and Safety of Suvratoxumab in Mechanically Ventilated Adults and Adolescents for the Prevention o...
Medical condition: Prevention of nosocomial pneumonia
Disease: Version SOC Term Classification Code Term Level
21.1 100000004862 10052596 Nosocomial pneumonia LLT
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: ES (Ongoing) FR (Ongoing) BE (Ongoing) NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-005713-13 Sponsor Protocol Number: 21102 Start Date: 2022-08-16
Sponsor Name: ACELYRIN, INC.
Full Title: A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Moderate to Severe Hidradenitis Suppurativa
Medical condition: Hidradenitis Suppurativa
Disease: Version SOC Term Classification Code Term Level
20.0 100000004858 10020041 Hidradenitis suppurativa LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) ES (Ongoing) HU (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-006709-31 Sponsor Protocol Number: COAV101B12302 Start Date: 2022-08-12
Sponsor Name: Novartis Pharma AG
Full Title: Phase IIIb, open-label, single-arm, multi-center study to evaluate the safety, tolerability and efficacy of OAV101 administered intrathecally (1.2 x 1014 vector genomes) to participants 2 to 12 yea...
Medical condition: Spinal Muscular Atrophy
Disease: Version SOC Term Classification Code Term Level
20.1 10010331 - Congenital, familial and genetic disorders 10041582 Spinal muscular atrophy PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-005029-26 Sponsor Protocol Number: KF7039-01 Start Date: 2022-08-08
Sponsor Name: Grünenthal GmbH
Full Title: A randomized, double-blind, placebo-controlled, Phase III trial to evaluate the efficacy and safety of intra-articular injections of RTX-GRT7039 in adult subjects with pain associated with osteoart...
Medical condition: Moderate to severe pain associated with osteoarthritis of the knee
Disease: Version SOC Term Classification Code Term Level
21.1 100000004859 10023476 Knee osteoarthritis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) NL (Ongoing) CZ (Ongoing)
Trial results: (No results available)
EudraCT Number: 2021-002629-95 Sponsor Protocol Number: 170188 Start Date: 2022-08-02
Sponsor Name: Surgical department, Aalborg University Hospital
Full Title: Cefuroxime and Piperacillin Concentrations in the Biliary System
Medical condition: Infection in the biliary system such as cholecystitis and cholangitis both as acute infections and post-operative infections.
Disease: Version SOC Term Classification Code Term Level
20.0 100000004871 10008618 Cholecystitis chronic NOS LLT
20.0 100000004871 10008615 Cholecystitis acute NOS LLT
20.0 100000004871 10008619 Cholecystitis NOS LLT
20.0 100000004871 10004638 Bile duct stone with cholecystitis LLT
20.0 100000004871 10007004 Calculus of gallbladder with acute cholecystitis LLT
20.0 100000004871 10006995 Calculus of bile duct with acute cholecystitis LLT
20.0 100000004871 10008606 Cholangitis acute NOS LLT
20.0 100000004871 10008608 Cholangitis NOS LLT
20.0 100000004871 10008607 Cholangitis chronic NOS LLT
20.1 100000004862 10056952 Septic cholangitis LLT
23.0 100000004862 10083504 Acute obstructive suppurative cholangitis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-006868-24 Sponsor Protocol Number: UMCN-AKF-21.05 Start Date: 2022-08-02
Sponsor Name: Radboud university medical centre
Full Title: Pharmacokinetics of fluconazole given orally or intravenously as prophylaxis or therapy to children and adolescents with invasive fungal infections (FOCUS)
Medical condition: Invasive fungal disease
Disease: Version SOC Term Classification Code Term Level
20.0 10021881 - Infections and infestations 10017533 Fungal infection PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)